Literature DB >> 3947483

Haemostatic function in myocardial infarction.

A Hamsten, M Blombäck, B Wiman, J Svensson, A Szamosi, U de Faire, L Mettinger.   

Abstract

Coagulation factor VIII, von Willebrand factor, antithrombin, fibrinogen, plasminogen activator capacity, and inhibitors of fibrinolysis, including a recently discovered fast inhibitor of tissue plasminogen activator, were measured three to six months after myocardial infarction in 116 male and 32 female patients aged less than 45 and in 136 age and sex matched random controls. Plasma concentrations of fibrinogen and the fast inhibitor of tissue plasminogen activator were raised in male patients (with or without correction for orosomucoid levels, blood group distribution, tobacco and alcohol consumption, and weight/height index) and plasminogen activator capacity was reduced. In female patients the concentrations of factor VIII, von Willebrand factor, the fast inhibitor of tissue plasminogen activator, alpha 2-antiplasmin, and C1 inhibitor were significantly increased. The increase in factor VIII concentrations depended strongly on a persisting inflammatory response. Multivariate analysis indicated that a combination of fibrinogen and tissue plasminogen activator inhibitor concentrations gave the best independent discrimination between male patients and controls. For female patients the best combination was von Willebrand factor and tissue plasminogen activator inhibitor. Male patients with multiple vessel atheromatosis at coronary angiography had higher fibrinogen concentrations than those with atheromatosis of a single vessel. Atheromatosis was defined as sharp-edged, plaque-like, or irregular indentations, often multiple, into the vessel lumen without features suggesting fibromuscular hyperplasia.

Entities:  

Mesh:

Year:  1986        PMID: 3947483      PMCID: PMC1232069          DOI: 10.1136/hrt.55.1.58

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  34 in total

1.  Use of glucose oxidase, peroxidase, and O-dianisidine in determination of blood and urinary glucose.

Authors:  A S HUGGETT; D A NIXON
Journal:  Lancet       Date:  1957-08-24       Impact factor: 79.321

2.  A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association.

Authors:  W G Austen; J E Edwards; R L Frye; G G Gensini; V L Gott; L S Griffith; D C McGoon; M L Murphy; B B Roe
Journal:  Circulation       Date:  1975-04       Impact factor: 29.690

3.  Electrophoretic separation of plasma lipoproteins in agarose gel.

Authors:  R P Noble
Journal:  J Lipid Res       Date:  1968-11       Impact factor: 5.922

Review 4.  Classification of hyperlipidaemias and hyperlipoproteinaemias.

Authors:  J L Beaumont; L A Carlson; G R Cooper; Z Fejfar; D S Fredrickson; T Strasser
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

5.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

6.  Blood coagulation and fibrinolysis in man after myocardial infarction compared with a representative population sample.

Authors:  K Korsan-Bengtsen; L Wilhelmsen; D Elmfeldt; G Tibblin
Journal:  Atherosclerosis       Date:  1972 Jul-Aug       Impact factor: 5.162

7.  A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro.

Authors:  R Ross; J Glomset; B Kariya; L Harker
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

8.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

9.  Blood changes in atherosclerosis and long after myocardial infarction and venous thrombosis.

Authors:  J R O'Brien; M D Etherington; S Jamieson; P Lawford; S V Lincoln; N J Alkjaersig
Journal:  Thromb Diath Haemorrh       Date:  1975-11-15

10.  A novel fast inhibitor to tissue plasminogen activator in plasma, which may be of great pathophysiological significance.

Authors:  B Wiman; J Chmielewska
Journal:  Scand J Clin Lab Invest Suppl       Date:  1985
View more
  14 in total

1.  The effect of acute aerobic exercise on hemostasis in obstructive sleep apnea.

Authors:  Ryan A Martin; Courtney Strosnider; Gabrielle Giersch; Christopher J Womack; Trent A Hargens
Journal:  Sleep Breath       Date:  2017-02-14       Impact factor: 2.816

2.  [Effect of exercise tolerance test on hemostasis in patients with and without coronary heart disease].

Authors:  M Lins; T Arendt; A Deutschmann; O Dieszbrock; U Steen; H D Bruhn
Journal:  Med Klin (Munich)       Date:  2000-01-15

Review 3.  Tissue-type plasminogen activator. A review of its pharmacology and therapeutic use as a thrombolytic agent.

Authors:  D Collen; H R Lijnen; P A Todd; K L Goa
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

Review 4.  Plasmin activation system in restenosis: role in pathogenesis and clinical prediction?

Authors:  G Christ; K Kostner; M Zehetgruber; B R Binder; D Gulba; K Huber
Journal:  J Thromb Thrombolysis       Date:  1999-06       Impact factor: 2.300

5.  Hemostatic Factors and Ischemic Heart Disease Risk Among Postmenopausal Women.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

6.  Relationship between job stress and plasma fibrinolytic activity in male Japanese workers.

Authors:  M Ishizaki; I Tsuritani; Y Noborisaka; Y Yamada; M Tabata; H Nakagawa
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

7.  Tissue type plasminogen activator antigen and activity in sickle cell disease.

Authors:  R B Francis
Journal:  J Clin Pathol       Date:  1988-05       Impact factor: 3.411

8.  [Persistent changes in tissue-type plasminogen activator and plasminogen activator inhibitor fibrinolytic parameters in patients following juvenile ischemic cerebral infarct].

Authors:  C Baumgartner; K Huber; F Holzner; K Zeiler; E Auff; B R Binder
Journal:  Klin Wochenschr       Date:  1988-11-15

9.  Effect of oral defibrotide on tissue-plasminogen activator and tissue-plasminogen activator inhibitor balance.

Authors:  F Violi; D Ferro; M Saliola; C Quintarelli; S Basili; F Balsano
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 10.  Clinical disorders of fibrinolysis: a critical review.

Authors:  R B Francis
Journal:  Blut       Date:  1989-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.